Last reviewed · How we verify
NCT03034733
The Effect of Dexamethasone on Pain After Total Knee Replacement Surgery
Phase 4 trial testing Dexamethasone in Arthroplasty, Knee Replacement in 27 participants. Terminated before completion.
31 January 2018
Quick facts
| Lead sponsor | University of Oulu |
|---|---|
| Phase | Phase 4 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 27 |
| Start date | 15 February 2017 |
| Primary completion | 31 January 2018 |
| Estimated completion | 31 January 2018 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- Dexamethasone (dexamethasone) — full drug profile →
- Sodium Chloride, (24)NaCl 0,9% — full drug profile →
Conditions studied
- Arthroplasty, Knee Replacement — all drugs for Arthroplasty, Knee Replacement →
- Pain, Postoperative — all drugs for Pain, Postoperative →
Sponsor
University of Oulu
Who can join
Adults 18 to 90, any sex, with Arthroplasty, Knee Replacement or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine, if a single-dose of dexamethasone given during the operation, alleviates pain after knee replacement surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Weibel S, Rücker G, Eberhart LH, Pace NL, et al · · 2020 · cited 125× · PMID 33075160 · DOI 10.1002/14651858.cd012859.pub2
Verify or expand the search:
- PubMed search for NCT03034733
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexamethasone
Trials testing the same drug.
- NCT07543458 — Therapeutics for Moderate and Severe Dengue · Phase 3 · not yet recruiting
- NCT07175415 — HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological · Phase 1, PHASE2 · not yet recruiting
- NCT07513129 — A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients · Phase 1 · not yet recruiting
- NCT07444710 — Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) · Phase 1 · not yet recruiting
- NCT07387926 — Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+ · Phase 1, PHASE2 · not yet recruiting
Other University of Oulu trials
Trials by the same sponsor.
- NCT07381933 — The Effect of Consumed Berries on Extracellular Vesicle Signalling in the Body · NA · recruiting
- NCT07280624 — Diagnostic PCR Panel in Children With Acute Gastrointestinal Symptoms · NA · not yet recruiting
- NCT05494684 — Effectiveness of Multisensoral Nature-based Intervention in Hospitalized Children During Venous Blood Sampling · NA · not yet recruiting
- NCT06711393 — The Effectiveness of Exergaming for Older People Mobility and Balance · NA · not yet recruiting
- NCT06171867 — PNEUMACRIT Device for Neonatal Cardio Respiratory Monitoring · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03034733 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oulu
- Last refreshed: 29 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03034733.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing